MedPath

Lanoxin

Brand Name: Lanoxin

Generic Name: Digoxin

Active
Registration Number

DR-XY48506

Dosage Form

Solution For Injection

Issuance Date

February 10, 2023

Expiry Date

November 28, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength250 mcg/mL (500 mcg/2mL)
PackagingUSP Type I clear glass ampoule x 2 mL (Box of 5's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial (correction)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

DigoxinActive
Monograph: Digoxin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform